Top sellers

Manufacturers

Infos

Accueil

New products

Alivecor Kardia ECG is used during COVID-19 pandemic

Published : 03/31/2020 09:49:51
Categories :

RED-DOLPHIN est partenaire d'ALIVECOR en Suisse et nous partageons ici des informations concernant le rôle que commence à jouer le dispositif Kardia AliveCor dans le cadre du suivi des traitements du COVID-19 (coronavirus).

Un certains nombres de traitement envisagés pour traiter le COVID-19 ont des effets (non désirés) qui peuvent affecter le rythme cardiaque. Aussi Kardia devient dans ce contexte un outil pour mesurer les impacts et s'assurer du contrôle des effets.

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

https://www.prnewswire.com/news-releases/new-fda-guidance-allows-use-of-kardiamobile-6l-to-measure-qtc-in-covid-19-patients-301028103.html

Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-provides-urgent-guidance-approach-to-identify-patients-at-risk-of-drug-induced-sudden-cardiac-death-from-use-of-off-label-covid-19-treatments/

Urgent Guidance for Navigating and Circumventing the QTc Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for COVID-19 (full document)

https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_covid19.pdf

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

Guidance for Industry and Food and Drug Administration Staff  (March 2020)

https://www.fda.gov/media/136290/download

Share this content

Add a comment

 (with http://)

PayPal